【摘 要】
：
Background: To evaluate the midterm results of percutaneous cryoablation for medically inoperable stage Ⅰ non-small cell lung cancer.Methodology/Principal Findings: Between January 2004 and June 2010,
【机 构】
：
Department of Surgery,School of Medicine,Keio University,Tokyo,Japan
论文部分内容阅读
Background: To evaluate the midterm results of percutaneous cryoablation for medically inoperable stage Ⅰ non-small cell lung cancer.Methodology/Principal Findings: Between January 2004 and June 2010, 160 patients underwent computer tomography guided percutaneous cryoablation for lung tumors at our institution.Of these patients, histologically proven stage Ⅰ lung cancer patients with more than one year of follow-up, were retrospectively reviewed.All of these patients were considered to be medically inoperable with Charlson comorbidity index of 3 or greater.Follow-up was based primarily on computed tomography.There were 22 patients with 34 tumors who underwent 25 sessions of cryoablation treatment.Complications were pneumothoraces in 7 treatments (28%, chest tube required in one treatment), and pleural effusions in 8 treatments (31%).The observation period ranged from 12-68 months, average 29619 months, median 23 months.Local tumor progression was observed in one tumor (3%).Mean local tumor progressionfree interval was 6962 months.One patient died of lung cancer progression at 68 months.Two patients died of acute exacerbations of idiopathic pulmonary fibrosis which were not considered to be directly associated with cryoablation, at 12 and 18 months, respectively.The overall 2-and 3-year survivals were 88% and 88%, respectively.Mean overall survival was 6264 months.Median overall survival was 68 months.The disease-free 2-and 3-year survivals were 78% and 67%, respectively.Mean disease-free survival was 4666 months.Pulmonary function tests were done in 16 patients (18 treatments) before and after cryoablation.Percentage of predicted vital capacity, and percentage of predicted forced expiratory volume in 1 second, did not differ significantly before and after cryoablation (93623 versus 90621, and 70611 versus 70612, respectively).Conclusions/Significance: Although further accumulation of data is necessary regarding efficacy, cryoablation may be a feasible option in medically inoperable stage Ⅰ lung cancer patients.
其他文献
目的 头颈癌的个体化诊断和治疗需要分子分类方法的支持.本研究的主要目的是建立头颈鳞癌分子分类技术和方法,并对潜在的生物标志物进行筛选、分析和验证,以确定头颈鳞癌分子诊断、分化程度、侵袭和转移等相关的分子靶点.材料与方法 在前期基因表达谱研究初步筛选的78个头颈鳞癌相关基因基础上,采用Real-time PCR的方法在mRNA水平检测了120例口腔颌面-头颈临床肿瘤组织标本和120例正常组织标本中7
Objective Dysregulated microRNAs (miRNAs) play an important role in many malignant tumors.However, elucidating the roles of miRNAs in cancer biology, especially m head and neck epithelial cancers, rem
非可控性炎症启动并参与了癌症的发生、发展、浸润转移和抵抗治疗等各个病理过程。研究表明癌变过程中调控的关键节点多和应激、炎症、免疫相关，炎症相关信号通路、尤其是NF-κB通路在慢性炎症癌变和转移中发挥关键调控作用；在口腔黏膜癌变过程中，上游miRNA基因调控网络发挥了十分关键的作用。报告重点介绍，以口腔癌前病变和口腔黏膜癌变模型为研究对象，针对癌启动、促进和发展过程，确立恶性转化时空节点的miRNA
Advances have been made in the past few decades in diagnosing cancers including improved imaging systems, endoscopies, and blood tests.However, significant portion of patients with cancer diagnosed at
Over the past decades, thermoablative techniques for the therapy of localized tumors have gained importance in the treatment of patients not eligible for surgical resection.Anecdotal reports have desc
HSF4 mutations lead to both congenital and age-related cataract.The purpose of this study was to explore the mechanism of cataract formation caused by HSF4 mutations.The degradation of nuclear DNA is
Objective Oral leukoplakia (OL) is the most common premalignant lesion in the site of oral cavity.However, only a small proportion of OLs progress to oral squamous cell carcinoma (OSCC).For early iden
Purpose: To evaluate the safety and feasibility of cryoablation for lung tumors as well as the incidence of, and risk factors for, complications.Materials and Methods: This study included 193 cryoabla
Primary lung cancer is the leading cause of cancer death in the United States.Lobectomy is the treatment of choice for early-stage non-small-cell lung cancer.For patients who are not suitable surgical
Purpose: To assess feasibility, complications, local tumor recurrences, overall survival (OS), and estimates of cost effectiveness for multisite cryoablation (MCA) of oligometastatic nonsmall-cell lun